Shape Memory Medical initiates pivotal trial for IMPEDE-FX in abdominal aortic aneurysm treatment
The AAA-SHAPE trial aims to evaluate the safety and effectiveness of IMPEDE-FX RapidFill in promoting aneurysm sac shrinkage post-EVAR.
Company
Pharmaceutical intelligence for IMPEDE-FX with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.